Customer reported that patient had been using interfering substances prior to sample collection.Customer was informed that topical medications can interfere with test performance as stated in the product package insert.No death, serious injury/illness or deterioration of health occured.Based on all clinical information available, patient was admitted and successfully delivered.Initial internal testing confirmed one false negative result and further investigation is pending.Customer results may have been affected by use of topical medications.In an abundance of caution this incident is being reported.The amnisure test is for use by healthcare professionals to aid in the diagnosis of rom in pregnant women reporting signs, symptoms or complaints suggestive of rom.Results should be used in conjunction with other clinical information and negative results alone may not rule out a membrane rupture.
|